Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhavya Voleti

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular Immunology|August 2, 2005
Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persistBhavya Voleti, Alok Agrawal
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoterBhavya Voleti, Alok Agrawal
Trends in Neurosciences|January 6, 2012
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agentsRonald S Duman, Bhavya Voleti
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoterPrem Prakash Singh, Bhavya Voleti, Alok Agrawal
Molecular Immunology|July 4, 2012
Oct-1 acts as a transcriptional repressor on the C-reactive protein promoterBhavya Voleti, David J Hammond, Avinash Thirumalai, et al.
Annals of Medicine|February 23, 2008
The connection between C-reactive protein and atherosclerosisSanjay K Singh, Madathilparambil V Suresh, Bhavya Voleti, et al.
Biological Psychiatry|September 23, 2011
Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depressionBhavya Voleti, Keith Q Tanis, Samuel S Newton, et al.
Scientific Reports|February 10, 2021
Astrocytic expression of the Alzheimer's disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical modelsAngela Marie Jablonski, Lee Warren, Marija Usenovic, et al.
Biological Psychiatry|June 12, 2013
Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responsesBhavya Voleti, Andrea Navarria, Rong-Jian Liu, et al.
Biological Psychiatry|June 24, 2010
Wnt2 expression and signaling is increased by different classes of antidepressant treatmentsHideki Okamoto, Bhavya Voleti, Mounira Banasr, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Immunology|August 2, 2005
Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persistBhavya Voleti, Alok Agrawal
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappaB on the proximal promoterBhavya Voleti, Alok Agrawal
Trends in Neurosciences|January 6, 2012
Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agentsRonald S Duman, Bhavya Voleti
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoterPrem Prakash Singh, Bhavya Voleti, Alok Agrawal
Molecular Immunology|July 4, 2012
Oct-1 acts as a transcriptional repressor on the C-reactive protein promoterBhavya Voleti, David J Hammond, Avinash Thirumalai, et al.
Annals of Medicine|February 23, 2008
The connection between C-reactive protein and atherosclerosisSanjay K Singh, Madathilparambil V Suresh, Bhavya Voleti, et al.
Biological Psychiatry|September 23, 2011
Analysis of target genes regulated by chronic electroconvulsive therapy reveals role for Fzd6 in depressionBhavya Voleti, Keith Q Tanis, Samuel S Newton, et al.
Scientific Reports|February 10, 2021
Astrocytic expression of the Alzheimer's disease risk allele, ApoEε4, potentiates neuronal tau pathology in multiple preclinical modelsAngela Marie Jablonski, Lee Warren, Marija Usenovic, et al.
Biological Psychiatry|June 12, 2013
Scopolamine rapidly increases mammalian target of rapamycin complex 1 signaling, synaptogenesis, and antidepressant behavioral responsesBhavya Voleti, Andrea Navarria, Rong-Jian Liu, et al.
Biological Psychiatry|June 24, 2010
Wnt2 expression and signaling is increased by different classes of antidepressant treatmentsHideki Okamoto, Bhavya Voleti, Mounira Banasr, et al.
Pageof 2